Elastrin Therapeutics, Inc.ET
SEC Form D filing

Elastrin Therapeutics, Inc.

Biotech · Seed · Regulation D 506(b) · SC · Filed March 11, 2025

Offering amount
$500.0K
Exemption
Reg D 506(b)
Issuer state
SC
Filing date
March 11, 2025
Signature date
—
CIK
0001848350

Summary

Elastrin Therapeutics biotech with $500k offering indicates seed stage.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.